MPL
Showing 1 - 25 of 160
Chronic Pain, Opioid Use, Cannabis Trial (CBD oil ( MPL-001), CDB+THC oil (MPL-005), Placebo oil)
Not yet recruiting
- Chronic Pain
- +2 more
- CBD oil ( MPL-001)
- +2 more
- (no location specified)
Apr 27, 2022
Acute Central Serous Chorioretinopathy Trial in Guangzhou (577-MPL, HD-PDT)
Completed
- Acute Central Serous Chorioretinopathy
- 577-MPL
- HD-PDT
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Apr 4, 2022
Type I Hypersensitivity Trial in Mississauga (RagweedMATAMPL, Placebo)
Withdrawn
- Type I Hypersensitivity
- RagweedMATAMPL
- Placebo
-
Mississauga, Ontario, CanadaAllied Research International Inc.
Aug 5, 2021
Type I Hypersensitivity Trial in Mississauga (Grass MATA MPL)
Completed
- Type I Hypersensitivity
- Grass MATA MPL
-
Mississauga, Ontario, CanadaAllied Research International Inc.
Jul 7, 2021
Chronic Migraine Trial in Vancouver, Halifax, Toronto (LGP1:20)
Not yet recruiting
- Chronic Migraine
-
Vancouver, British Columbia, Canada
- +2 more
Nov 16, 2022
Type I Hypersensitivity Trial in Mississauga (Tree MATA MPL - Therapeutic Regimen, Tree MATA MPL - Intermediate dose, Tree MATA
Completed
- Type I Hypersensitivity
- Tree MATA MPL - Therapeutic Regimen
- +3 more
-
Mississauga, Ontario, CanadaAllied Research International Inc.
Feb 5, 2021
Seasonal Allergic Rhinitis Trial in Neptune (Placebo (0.5ml), Placebo (1.0ml), Grass MATA MPL (0.5ml) 5100SU)
Completed
- Seasonal Allergic Rhinitis
- Placebo (0.5ml)
- +5 more
-
Neptune, New JerseyInflamax Research Inc.
Jan 28, 2021
Knee Osteoarthritis Trial in Hamilton (MPL-001 (CBD: THC 25:1), Placebo oil for oral use)
Not yet recruiting
- Knee Osteoarthritis
- MPL-001 (CBD: THC 25:1)
- Placebo oil for oral use
-
Hamilton, Ontario, Canada
- +1 more
Jul 13, 2022
COVID-19 Infections and Re-infection
Recruiting
- Covid-19
- SARS-CoV Infection
-
Montpellier, FranceUh Montpellier
Jan 3, 2022
Type I Hypersensitivity Trial in Mississauga, Ottawa (Grass MATAMPL)
Completed
- Type I Hypersensitivity
- Grass MATAMPL
-
Mississauga, Ontario, Canada
- +2 more
May 17, 2021
Type I Hypersensitivity Trial in United States (RagweedMATAMPL)
Completed
- Type I Hypersensitivity
- RagweedMATAMPL
-
Novi, Michigan
- +3 more
Jun 9, 2021
Type I Hypersensitivity Trial in Mississauga (Tree MATA MPL or Tree MATA)
Terminated
- Type I Hypersensitivity
- Tree MATA MPL or Tree MATA
-
Mississauga, Ontario, CanadaAllied Research International Inc.
Nov 26, 2020
Dyslipidemias, Obesity Trial in Storrs (Milk Polar Lipid-Rich Dairy Powder, Dairy Powder)
Not yet recruiting
- Dyslipidemias
- Obesity
- Milk Polar Lipid-Rich Dairy Powder
- Dairy Powder
-
Storrs, ConnecticutUniversity of Connecticut
Jan 18, 2023
Healthy Volunteers, Norovirus Trial in Belgium, United States (NoV Vaccine)
Completed
- Healthy Volunteers
- Norovirus
- NoV Vaccine
-
Birmingham, Alabama
- +10 more
Nov 7, 2022
Sickle Cell Disease, Sickle Cell Anemia Trial run by the NHLBI (Biotin label)
Recruiting
- Sickle Cell Disease
- Sickle Cell Anemia
- Biotin label
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 11, 2022
Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])
Recruiting
- Pre-fibrotic Myelofibrosis
- Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
-
Taipei, Taiwan, 100, TaiwanNational Taiwan University Hospital
Feb 7, 2023
Retinitis Pigmentosa, Cystoid Macular Edema Trial in Ankara (SL-MPL treatment protocol was performed with a 577 nm yellow laser
Completed
- Retinitis Pigmentosa
- Cystoid Macular Edema
- SL-MPL treatment protocol was performed with a 577 nm yellow laser (EasyRet, Quantel Medical, Cedex, France)
-
Ankara, Türkiye, Turkey
- +1 more
Jan 21, 2020
Monocytes Sub-populations in Thrombosis Associated With
Recruiting
- Myeloproliferative Neoplasm
- 1 additional tube of blood
-
Bordeaux, France
- +4 more
Nov 30, 2022
Serum Cholesterol, Gut Microbiome Trial in Storrs (Milk Polar Lipids, Milk Fat)
Completed
- Serum Cholesterol
- Gut Microbiome
- Milk Polar Lipids
- Milk Fat
-
Storrs, ConnecticutUniversity of Connecticut
Jan 11, 2022
Central Serous Choroidopathy Trial in Wenzhou (577-MPL, TLT)
Completed
- Central Serous Choroidopathy
- 577-MPL
- TLT
-
Wenzhou, Zhejiang, ChinaThe eye of Wenzhou Medical University
Jul 17, 2019
Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)
Recruiting
- Polycythemia Vera
- Ruxolitinib
- Pegylated interferon α-2b
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
May 19, 2023
Medically Assisted Fertilization Techniques in Systemic
Recruiting
- Rheumatic Diseases
- +4 more
- collection and analysis of treatments and procedures already performed by normal clinical practice
-
Milan, ItalySan Raffaele Hospital
Mar 28, 2023
Tumors, Non-Neoplastic, Bile Duct Tumors Trial in Guayaquil (DSOC with AI biopsy guidance, DSOC biopsy without AI guidance)
Active, not recruiting
- Neoplasms
- +3 more
- DSOC with AI biopsy guidance
- DSOC biopsy without AI guidance
-
Guayaquil, Guayas, EcuadorCarlos Robles-Medranda
Aug 8, 2022
Seasonal Allergic Rhinitis Trial in United States (Placebo comparator, Grass MATA MPL)
Completed
- Seasonal Allergic Rhinitis
- Placebo comparator
- Grass MATA MPL
-
Edison, New Jersey
- +3 more
Apr 29, 2019